Cencora
Cencora, Inc. (NYSE: COR) is a global pharmaceutical sourcing and distribution services company serving healthcare providers and pharmaceutical and biotechnology manufacturers. It distributes brand-name, specialty and generic pharmaceuticals, over-the-counter products, home healthcare supplies and equipment, and… From the company’s description.
In fiscal 2025, Cencora reported revenue of $321.33B, up 9.3% from fiscal 2024, and net income of $1.57B. Its operating margin was 0.8%, and operations generated $3.88B in cash. Over the twelve months to Jun 30, 2026, revenue was $332.77B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Cencora does
In the company’s own words
Cencora, Inc. (NYSE: COR) is a global pharmaceutical sourcing and distribution services company serving healthcare providers and pharmaceutical and biotechnology manufacturers. It distributes brand-name, specialty and generic pharmaceuticals, over-the-counter products, home healthcare supplies and equipment, and animal health products, and provides services including specialty logistics, data analytics, reimbursement and regulatory consulting, inventory management, pharmacy automation, and packaging. Its customers include hospitals and health systems, retail and mail-order pharmacies, clinics, physician practices, veterinarians, and drug manufacturers. Cencora reports two segments: U.S. Healthcare Solutions, which distributes medicines and provides related services to U.S. providers and manufacturers, including animal health offerings; and International Healthcare Solutions, which distributes healthcare products and provides commercialization, logistics, and life sciences services primarily in Europe and Canada. The company acquired an 85% interest in Retina Consultants of America in 2025, expanding its specialty-provider relationships. Cencora had more than 51,000 employees globally as of September 30, 2025. Its website is www.cencora.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Wholesale
- Headquarters
- CONSHOHOCKEN, PA
- Fiscal year end
- September
- CIK
- 1140859
- SIC
- 5122
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Cencora — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Cencora’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Cencora’s bonds, as funds hold them
Funds report holding 16 issues of Cencora’s debt, $1.50B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.19%, maturing 2027 to 2056.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Cencora and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Cencora's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Cencora's last four quarterly filings that the numbers alone won't show?”